Vis, A., Altena, E. V., Jansen-Stensland, B., Koppes, J., Oprea-Lager, D. (2026). The DUET-1 trial: Feasibility and toxicity outcomes and early oncological outcomes of
177
lutetium-PSMA radioligand therapy (RLT) alternated with
233
radium-dichloride in patients with metachronous oligorecurrent osseus hormone sensitive prostate cancer (mHSPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17083